Уважаемые пользователи!
Мы рады представить вам новую версию сайта с улучшенным интерфейсом и новыми возможностями.
Приглашаем вас ознакомиться и поделиться обратной связью. Спасибо, что вы с нами!
Попробовать!

Long-term effects of statin use linked to increased kidney disease, injury

10.12.20151973
During a follow-up period of approximately 6 years, use of statin therapy was associated with increased incidence of acute kidney injury and chronic kidney disease, according to new findings.

Moderate-intensity statins may reduce heart failure in type 2 diabetes

09.12.20151961
Moderate-intensity statin therapy reduced heart failure incidence in type 2 diabetes compared with low-intensity or no statin, according to recent study findings.

Cardio Update Europe 2016: cooperation offer for RSC members

09.12.20152052
RSC is pleased to announce that within the cooperation Cardio Update Europe RSC members got an exciting opportunity to visit this congress for free!

TATORT-NSTEMI: Thrombus aspiration fails to improve outcomes at 1 year

08.12.20151956
Routine thrombus aspiration before PCI did not result in significantly improved health outcomes in patients with non-STEMI during the first year after the procedure, according to results of the TATORT-NSTEMI trial published in the European Heart Journal: Acute Cardiovascular Care.

ADAPT-DES: PPI increased high platelet reactivity in DES setting

07.12.20152069
Concomitant administration of proton pump inhibitors and dual antiplatelet therapy yielded increased rates of high platelet reactivity in patients undergoing PCI with drug-eluting stents, according to results from the ADEPT-DES registry.

Modest physical activity lowers CVD risk in older adults

04.12.20151928
Engaging in even modest physical activity was associated with lower risk for CHD, stroke and CVD in older adults, according to the results of a prospective cohort study.

Novel oral anticoagulants may reduce stroke, bleeding risk in patients with renal impairment

03.12.20152002
In patients with mild or moderate renal impairment, the use of novel oral anticoagulants appears to confer reduced risks for stroke or systemic embolism, as well as for major bleeding, compared with warfarin, according to research published in The American Journal of Cardiology.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.